WO2005086064A3 - Drug administration support system - Google Patents

Drug administration support system Download PDF

Info

Publication number
WO2005086064A3
WO2005086064A3 PCT/IB2005/050729 IB2005050729W WO2005086064A3 WO 2005086064 A3 WO2005086064 A3 WO 2005086064A3 IB 2005050729 W IB2005050729 W IB 2005050729W WO 2005086064 A3 WO2005086064 A3 WO 2005086064A3
Authority
WO
WIPO (PCT)
Prior art keywords
drug
clearance
drug administration
guideline
administration support
Prior art date
Application number
PCT/IB2005/050729
Other languages
French (fr)
Other versions
WO2005086064A2 (en
Inventor
Yasuhiro Kuroda
Toshiya Okahisa
Yoshiaki Ohnishi
Original Assignee
Koninkl Philips Electronics Nv
Yasuhiro Kuroda
Toshiya Okahisa
Yoshiaki Ohnishi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Koninkl Philips Electronics Nv, Yasuhiro Kuroda, Toshiya Okahisa, Yoshiaki Ohnishi filed Critical Koninkl Philips Electronics Nv
Publication of WO2005086064A2 publication Critical patent/WO2005086064A2/en
Publication of WO2005086064A3 publication Critical patent/WO2005086064A3/en

Links

Classifications

    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
    • G16H10/40—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for data related to laboratory analysis, e.g. patient specimen analysis
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H70/00—ICT specially adapted for the handling or processing of medical references
    • G16H70/40—ICT specially adapted for the handling or processing of medical references relating to drugs, e.g. their side effects or intended usage

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Primary Health Care (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • External Artificial Organs (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

The total clearance of a drug is calculated based on the blood filtering information, biological information and drug information. The total clearance is displayed on a drug administration support screen (24). The drug administration support screen (24) provides a guideline of the dose of a drug which varies dependent on the level of the renal creatinine clearance. Specifically, the renal clearance of the drug and the clearance of the drug due to continual hemofiltration (CHF) are shown in a graphical form, and a guideline of the dose of the drug is provided which varies dependent on the level of the total clearance. Accordingly, the user can easily recognize the meaning of the guideline by referring to the total clearance of the drug shown in the graph. The drug administration support display screen (24) also provides additional information necessary for drug administration as appropriate.
PCT/IB2005/050729 2004-03-03 2005-03-01 Drug administration support system WO2005086064A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004-058749 2004-03-03
JP2004058749A JP2005245667A (en) 2004-03-03 2004-03-03 Medicine administration design system

Publications (2)

Publication Number Publication Date
WO2005086064A2 WO2005086064A2 (en) 2005-09-15
WO2005086064A3 true WO2005086064A3 (en) 2006-06-01

Family

ID=34917944

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2005/050729 WO2005086064A2 (en) 2004-03-03 2005-03-01 Drug administration support system

Country Status (3)

Country Link
JP (1) JP2005245667A (en)
CN (1) CN1930571A (en)
WO (1) WO2005086064A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102665790B (en) * 2009-12-17 2016-11-16 尼普洛株式会社 Haemodialysis equipment
JP6394997B2 (en) * 2016-01-09 2018-09-26 国立大学法人 熊本大学 Drug audit program and drug audit system for dispensing operation support

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520486A2 (en) * 1991-06-28 1992-12-30 Shunro Tachibana Blood processing apparatus for treating blood disease
EP1364666A1 (en) * 2000-12-27 2003-11-26 Philips Japan, Ltd Biological information and blood treating device information control system, biological information and blood treating device information control device, and biological information and blood treating device information control method

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020010550A1 (en) * 1998-09-14 2002-01-24 George M. Grass Pharmacokinetic-based drug design tool and method
KR20020063174A (en) * 1999-11-03 2002-08-01 하워드 제이 스미스 앤드 어쏘시에이츠 피티와이 엘티디 Liver selective therapy
JP2001337998A (en) * 2000-05-26 2001-12-07 Terumo Corp Medical monitor system, control method thereof, and computer-readable memory

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0520486A2 (en) * 1991-06-28 1992-12-30 Shunro Tachibana Blood processing apparatus for treating blood disease
EP1364666A1 (en) * 2000-12-27 2003-11-26 Philips Japan, Ltd Biological information and blood treating device information control system, biological information and blood treating device information control device, and biological information and blood treating device information control method

Also Published As

Publication number Publication date
WO2005086064A2 (en) 2005-09-15
JP2005245667A (en) 2005-09-15
CN1930571A (en) 2007-03-14

Similar Documents

Publication Publication Date Title
Gatidou et al. Drugs of abuse and alcohol consumption among different groups of population on the Greek Island of Lesvos through sewage-based epidemiology
WO2006037802A3 (en) Method and system for self- management of a disease
Niwa Removal of protein-bound uraemic toxins by haemodialysis
WO2006009751A3 (en) System and method for monitoring disease progression or response to therapy using multi-modal visualization
WO2008019013A3 (en) Interface for medical infusion pump
WO2007049164A3 (en) Interactive patient care system
AU2003251804A1 (en) Intra-aortic renal drug delivery catheter
WO2007038060A3 (en) Modular infusion pump having two different energy sources
WO2007070684A3 (en) Clinical decision support system
NO20053150D0 (en) System for administering medicine.
WO2008100908A3 (en) Method and system for providing financial services
WO2006009675A3 (en) System and method for linking vois across timepoints for analysis of disease progression or response to therapy
WO2007011930A3 (en) Systems, user interfaces, and methods for processing medical data
Neirynck et al. Review of protein-bound toxins, possibility for blood purification therapy
WO2006022925A3 (en) Game console and emulator for the game console
AU2003291361A1 (en) Flashback blood collection needle
EP1884898A3 (en) Systems and methods for rule-based volume rendition and navigation
WO2005086064A3 (en) Drug administration support system
WO2003094933A3 (en) Use of lanthanum for the treatment of hypercalcemia and bone metastasis
WO2005101191A3 (en) System and method for a virtual content repository
WO2005081163A3 (en) Method for the selection of a participant in a medical project with selection criteria for patients
WO2009027843A3 (en) Techniques for purposing a new compound and for repurposing a drug
AU2003257814A1 (en) Medicinal composition for lowering blood lipid level
FR2907857B1 (en) DEVICE FOR MEETING / RAPID SEPARATION OF TWO ELEMENTS, SUCH AS AN OFFICE TRAY AND A FOOT
Gentil et al. Influence of the current management of renal transplant recipients on the prevalence of anemia and related costs

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 200580007003.7

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP

122 Ep: pct application non-entry in european phase